News and blogs
377 results found.
Putting equality, diversity and inclusion at the heart of our mission
Discover how Blood Cancer UK is putting equality, diversity and inclusion at the heart of it's work.
Why am I being invited for another Covid vaccine? - Third doses and boosters
Anyone who is immunocompromised, including anyone with blood cancer, is now eligible for a booster (fourth dose) of the Covid vaccine, to be given three months after their third primary dose. In this blog, we explain more.
"I am incredibly happy to be alive and I am glad I took part [in the clinical trial]"
When Shibu was diagnosed with blood cancer in 2006, cord blood transplants were a 'new concept'. After struggling to find a bone marrow donor, Shibu was offered a place on a trial where he'd receive a cord blood transplant. Here's how it went.
Imagine being told, at 23, that you have cancer
"Our lives are wonderful and will continue to be so. Cancer isn’t the be all and end all. My life was flipped over by cancer, but now, I have seen the person I never knew I was." - Jika Edström
The Big C: Cancer or Covid? - Nichola's story
Read Nichola's story about mistaking Hodgkin lymphoma. symptoms for long-Covid, beating the blood cancer into remission and taking on the Jog 26.2 mile challenge.
Antivirals and monoclonal antibodies – what’s the difference?
We’ve been hearing about new treatments that the UK have bought to tackle Covid. Some drugs have already been approved for use in the UK, some are yet to be – but the hope is that they will help those most at risk of severe Covid.
How did the third Covid vaccine dose roll-out go so badly wrong?
We take an in-depth look at a timeline of delays, missed opportunities, and mistakes which have caused huge anxiety among people with blood cancer – and may have even led to avoidable deaths.
Our guidance around attending events in Autumn
With many of the blood cancer community more vulnerable to Covid, we outline our policy on in-person events taking place in the autumn period.
How re-purposing drugs could revolutionise blood cancer treatment
Find out how re-purposing drugs could help us bring new treatments to people with blood cancer, faster.
Survival rates for children and young people with leukaemia and lymphoma sees big increase
Learn more about the increase of children and young people with lymphoma and leukaemia who are surviving and beating blood cancer.
Childhood blood cancer survival rates see big improvement
Improvements to blood cancer treatments mean an extra one in 10 children and young people now survives leukaemia and lymphoma compared to 20 years ago, according to a new analysis by our charity.
Analysis finds 1 in 20 Covid intensive care patients are immunocompromised
Immunocompromised people now account for 1 in 20 Covid patients being admitted to intensive care, according to our new analysis of the data.
Just 44% of people with blood cancer invited for potentially lifesaving third vaccine dose
The roll-out of the third dose of Covid vaccines to the immunocompromised has been a chaotic failure, with less than half of people with blood cancer being invited by the deadline set by the NHS, according to our new survey.
New Christmas cards released in memory of Emma McKinlay
Blood Cancer UK have released new Christmas card designs in memory of the late artist Emma McKinlay.
Blood cancer and your employment rights
Ben Goodall from Acas explains how employees with blood cancer are protected by law, and how to handle discussions with your employer about the impact blood cancer has on your working life, especially during the current pandemic.
Supporting people with blood cancer to make decisions around clinical trials
Find out how Millie, an Advanced Nurse Practitioner, helps people with blood cancer take decisions on blood cancer clinical trials.
What should you do if you have blood cancer and cannot get a third Covid vaccine dose?
With many people reporting issues with the rollout of third doses of the vaccine, we’ve set out what you can do right now to try to get your third dose if you have not already been invited for it.
What does Sajid Javid’s letter to the clinically extremely vulnerable mean?
We've read the 2,000 word letter, digested it, and sum up the key points in 179 words.
My birthday surprise… blood cancer
Due to the severity of his condition, Sunny didn't have time to digest the news of his diagnosis. Now, he has some advice for you.
Blood Cancer UK research strategy - your questions answered
Read more about Blood Cancer UK's research strategy, find out how we will allocate funding, and how soon research should deliver impact for patients.
